23259871

Katulande P

2013

Multicystic ovaries and pituitary pseudo-adenoma associated with primary hypothyroidism.

23260096

Roe AH

2013

Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents.

23261983

Bates GW

2013

Longterm management of Polycystic Ovarian Syndrome (PCOS).

23262934

Lawrence JM

2013

Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007.

23263174

Fenkci SM

2013

Serum calcitonin gene-related peptide levels in women with polycystic ovary syndrome.

23265956

Xie GB

2013

Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: a case-control study and meta-analysis.

23265961

Sang Q

2013

Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.

23267369

Mehrabian F

2012

Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls.

23270212

Yawn V

2012

Polycystic ovarian syndrome.

23275352

Yang M

2013

Zinc-?2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.

23276559

Lin MW

2012

Vitamin D receptor 1a promotor -1521 G/C and -1012 A/G polymorphisms in polycystic ovary syndrome.

23276562

Chang CY

2012

Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.

23278116

Karuputhula NB

2013

Oxidative status in granulosa cells of infertile women undergoing IVF.

23278130

Kahal H

2013

Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity.

23278234

Paltoglou G

2013

PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenaemia.

23279603

Esfahanian F

2013

Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.

23281358

Gray SH

2013

Menstrual disorders.

23282707

Sir-Petermann T

2012

[Polycystic ovary syndrome and pregnancy].

23283052

Ziaee A

2012

Association between metabolic syndrome and premicroalbuminuria among Iranian women with Polycystic Ovary Syndrome: a case control study.

23283740

Zou S

2013

Common genetic variation in CYP1B1 is associated with concentrations of T?, FT? and FT? in the sera of polycystic ovary syndrome patients.

23284011

Kowalska I

2013

Serum visfatin is differentially regulated by insulin and free Fatty acids in healthy men.

23286960

Sermondade N

2013

[Impact of polycystic ovary syndrome on oocyte and embryo quality].

23288220

Rodrigues CE

2012

Evaluation of common mental disorders in women with polycystic ovary syndrome and its relationship with body mass index.

23289266

Krysiak R

2012

[Diabetes and prediabetes in endocrine disorders].

23289590

Dong Z

2013

Associations of acanthosis nigricans with metabolic abnormalities in polycystic ovary syndrome women with normal body mass index.

23292354

Cho M

2013

The clinical ramifications of polycystic ovarian morphology in oocyte donors.

23292744

Brown M

2013

Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age-matched controls.

23294318

Anagnostis P

2013

Vitamin D in human reproduction: a narrative review.

23295201

AlHilli MM

2013

Long-term outcomes after intrauterine morcellation vs hysteroscopic resection of endometrial polyps.

23298894

Dubourdieu S

2013

Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH+LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndrome.

23302121

Wei LN

2012

[Change and significance of growth differentiation factor 9 and bone morphogenetic protein expression during oocyte maturation in polycystic ovary syndrome patients with ovarian stimulation].

23302728

Wang XX

2012

[Pregnancy outcomes of in vitro fertilization and embryo transfer in infertile women with polycystic ovarian syndrome].

23303572

Murri M

2013

Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.

23303986

Nestler JE

2012

A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome.

23304157

Woodard TL

2012

Malignant transformation of endometrioma in a woman with a history of ovulation induction and in vitro fertilization.

23305451

Hac?hanefio?lu B

2013

Association of anthropometric, androgenic and insulin-related features with polymorphisms in exon 8 of SHBG gene in women with polycystic ovary syndrome.

23307315

Jalilian N

2013

Phytotherapeutic management of polycystic ovary syndrome: role of aerial parts of wood betony (Stachys lavandulifolia).

23311996

Bird ST

2013

Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines.

23314524

Poomthavorn P

2013

Glucose metabolism in obese and lean adolescents with polycystic ovary syndrome.

23315058

Tziomalos K

2013

Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.

23315061

Stepto NK

2013

Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

23315226

S?godi L

2013

[Peripubertal ovarian cyst torsion as an early complication of undiagnosed polycystic ovarian syndrome].

23315599

Romualdi D

2013

How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation.

23316887

B?ttcher B

2013

Ultrasonographic assessment of skin thickness in patients with PCOS - a case-control study.

23318877

Sprung VS

2013

Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training.

23318879

Jungbauer A

2014

Phytoestrogens and the metabolic syndrome.

23319372

Deveci I

2013

Effects of polycystic ovary syndrome and menopause on rat soft palate and base of tongue.

23320765

Fenton A

2013

Anti-M?llerian hormone - is it a clinically useful test?

23321213

Pierre A

2013

Loss of LH-induced down-regulation of anti-M?llerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.

23322284

Chakraborty P

2013

Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome.

23327607

Barcellos CR

2013

Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.

23327624

Vera L

2013

Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature.

23327685

Paradisi R

2013

Ovulatory effects of flutamide in the polycystic ovary syndrome.

23327719

?z?aka ?

2013

Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation?

23330582

Morton A

2013

Neutrophil leucocytosis and polycystic ovarian syndrome--could elevated noradrenaline levels due to obstructive sleep apnoea be a contributing mechanism?

23335609

Hemmings KE

2013

Amino acid turnover by human oocytes is influenced by gamete developmental competence, patient characteristics and gonadotrophin treatment.

23335611

Celik C

2013

Assessment of impaired glucose tolerance prevalence with hemoglobin A?c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study.

23335723

S?godi L

2013

[Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls].

23335807

Chen X

2013

Adipokines in reproductive function: a link between obesity and polycystic ovary syndrome.

23336594

Artini PG

2013

Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.

23337418

Raga F

2013

HDlive ultrasound images in assisted reproduction treatment.

23337724

Mart?nez-Garc?a M?

2013

Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS).

23338533

Kim YS

2013

Apolipoprotein A-IV as a novel gene associated with polycystic ovary syndrome.

23338549

Oliveira Rdo S

2013

Arterial hypertension and metabolic profile in patients with polycystic ovary syndrome.

23339008

Kr?pu?a K

2012

Psychiatric disorders related to polycystic ovary syndrome.

23339653

Pepene CE

2013

Serum under-carboxylated osteocalcin levels in women with polycystic ovary syndrome: weight-dependent relationships with endocrine and metabolic traits.

23346251

Neagu M

2012

Anti-M?llerian hormone--a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome.

23346527

Choi MH

2012

Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles.

23347605

Kamel HH

2013

Role of phyto-oestrogens in ovulation induction in women with polycystic ovarian syndrome.

23348399

Montes-Nieto R

2013

A nontargeted proteomic study of the influence of androgen excess on human visceral and subcutaneous adipose tissue proteomes.

23349861

Johansson J

2013

Electrical vs manual acupuncture stimulation in a rat model of polycystic ovary syndrome: different effects on muscle and fat tissue insulin signaling.

23350621

Kedikova SE

2013

Leptin levels and adipose tissue percentage in adolescents with polycystic ovary syndrome.

23350701

Yilmaz E

2013

Serum orexin-A (OXA) level decreases in polycystic ovarian syndrome.

23352610

Corbett S

2013

The Polycystic Ovary Syndrome and recent human evolution.

23355935

De Leonibus C

2012

Update on statural growth and pubertal development in obese children.

23357457

Thomson RL

2013

Seasonal effects on vitamin D status influence outcomes of lifestyle intervention in overweight and obese women with polycystic ovary syndrome.

23358726

Farimani Sanoee M

2011

Metformin therapy decreases hyperandrogenism and ovarian volume in women with polycystic ovary syndrome.

23359971

Zeng L

2012

[Comparative study on Chinese medical syndrome typing and treatment combined different surgical methods for treating clomiphene-resistant polycystic ovary syndrome].

23361456

Abd Elgafor I

2013

Efficacy of combined metformin-letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome.

23362058

Ferraria N

2013

Berardinelli-Seip syndrome: highlight of treatment challenge.

23362921

Atkin SL

2013

Cardiovascular disease in polycystic ovary syndrome.

23368758

Ebejer K

2013

The role of cytokines in polycystic ovarian syndrome.

23369089

Chen R

2013

Mitochondrial DNA mutations may not be frequent in patients with polycystic ovary syndrome.

23370180

Abbott DH

2013

Nonhuman primate models of polycystic ovary syndrome.

23371438

Xu P

2013

Haplotype analysis of single nucleotide polymorphisms in anti-M?llerian hormone gene in Chinese PCOS women.

23375040

Xia YH

2013

Correlation between IL-1?, IL-1Ra gene polymorphism and occurrence of polycystic ovary syndrome infertility.

23375202

Pau C

2013

Evaluating reported candidate gene associations with polycystic ovary syndrome.

23376852

Rashidi BH

2013

Effects of acupuncture on the outcome of in vitro fertilisation and intracytoplasmic sperm injection in women with polycystic ovarian syndrome.

23377194

Cakiroglu Y

2013

The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.

23377771

Homburg R

2013

The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.

23379651

Begum MR

2013

Pretreatment and co-administration of oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome.

23380185

Grynberg M

2013

In?vitro maturation of oocytes: uncommon indications.

23380369

Light A

2013

Membrane receptor cross talk in steroidogenesis: recent insights and clinical implications.

23381551

Coskun S

2013

Gene expression profiling of granulosa cells from PCOS patients following varying doses of human chorionic gonadotropin.

23382852

Galazis N

2013

Proteomic biomarkers of preterm birth risk in women with polycystic ovary syndrome (PCOS): a systematic review and biomarker database integration.

23384539

Williams RM

2013

Polycystic ovarian syndrome during puberty and adolescence.

23386413

Settas N

2013

CYP21A2 mutations in women with polycystic ovary syndrome (PCOS).

23386652

Borruel S

2013

Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS).

23388061

King SM

2013

Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway.

23390562

Feng Y

2013

Genetic modeling of ovarian phenotypes in mice for the study of human polycystic ovary syndrome.